J. Mohler1, P. Moine1, E. Azoulay-Dupuis1, D. Henin2, B. Fantin1
European Cytokine Network, Vol.18, No.1, pp. 1-8, 2007, DOI:10.1684/ecn.2007.0082
Abstract We used a Balb/c mouse model of pneumococcal pneumonia to investigate the protection
mechanisms induced by immunization with a polyvalent 23 epitope polysaccharide pneumonia vaccine. Groups
of mice were injected x 4 times s.c. within one month, with this vaccine preparation. Mice were subsequently
challenged at day 45, with a lethal, intratracheal inoculum of two strains of Streptococcus pneumoniae – either a
highly virulent and strongly immunogenic serotype 3 strain (P4241), or a less virulent and weakly immunogenic
serotype 19F strain (P15986). The intratracheal S. pneumoniae challenge-induced lethality, antibody response,
bacterial clearance, and cytokine secretions were monitored… More >